Lack of association of GSTT1 and GSTP1 genes methylation and their expression profiles with risk of NAFLD in a sample of Iranian patients

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 5, 2011, Pages 387-392

  Kordi Tamandani, Dor Mohammad ^a   Hashemi, Mohammad ^b   Birjandian, Elnaz ^a   Bahari, Ali ^c   Valizadeh, Jafar ^a   Torkamanzehi, Adam ^a  

^a UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MESSENGER RNA;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; FATTY LIVER; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IRAN; METHYLATION;

EID: 79956355802     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.01.015     Document Type: Article

References (41)

1. Neuschwander-Tetri B.A., Caldwell S.H. Non alcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
2. Sass D.A., Chang P., Chopra K.B. Non alcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005, 50:171-180.
3. Sotoudehmanesh R., Sotoudeh M., Ali-Asgari A., Abedi-Ardakani B., Tavangar S.M., Khakinejad A., et al. Silent liver diseases in autopsies from forensic medicine of Tehran. Arch Iran Med 2006, 9:324-328.
4. Sanyal A.J. AGA technical review on non alcoholic fatty liver disease. Gastroenterology 2002, 123:1705-1725.
5. Giday S.A., Ashiny Z., Naab T., Smoot D., Banks A. Frequency of non alcoholic fatty liver disease and degree of hepatic steatosis in African-American patients. J Natl Med Assoc 2006, 98:1613-1615.
6. Brunt E.M. Pathology of non alcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010, 7:195-203.
7. Wilfred de Alwis N.M., Day C.P. Genes and nonalcoholic fatty liver disease. Curr Diab Rep 2008, 8:156-163.
8. Lewis J.R., Mohanty S.R. Non alcoholic fatty liver disease: a review and update. Dig Dis Sci 2010, 55:560-578.
9. Satoh S., Daigo Y., Furukawa Y., Kato T., Miwa N., Nishiwaki T., et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000, 24:245-250.
10. Fujie H., Moriya K., Shintani Y., Tsutsumi T., Takayama T., Makuuchi M., et al. Frequent beta-catenin aberration in human hepatocellular carcinoma. Hepatol Res 2001, 20:39-51.
11. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(Suppl.):245-254.
12. Kiefer J.C. Epigenetics in development. Dev Dyn 2007, 236:1144-1156.
13. Miyoshi H., Fujie H., Moriya K., Shintani Y., Tsutsumi T., Makuuchi M., et al. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma. J Gastroenterol 2004, 39:563-569.
14. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
15. Cui J.Y., Choudhuri S., Knight T.R., Klaassen C.D. Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol Sci 2010, 116:32-43.
16. Masoudi M., Saadat I., Omidvari S., Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 2009, 36:781-784.
17. Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M.K., Warholm M., et al. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A 1985, 82:7202-7206.
18. Csejtei A., Tibold A., Varga Z., Koltai K., Ember A., Orsos Z., et al. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Res 2008, 28:1917-1922.
19. Pearson W.R., Vorachek W.R., Xu S.J., Berger R., Hart I., Vannais D., et al. Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 1993, 53:220-233.
20. Abu-Amero K.K., Al-Boudari O.M., Mohamed G.H., Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet 2006, 7:38.
21. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000, 463:247-283.
22. Rossini A., Rapozo D.C., Soares Lima S.C., Guimaraes D.P., Ferreira M.A., Teixeira R., et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. Carcinogenesis 2007, 28:2537-2542.
23. Tijhuis M.J., Wark P.A., Aarts J.M.M.J.G., Visker M.H.P.W., Nagengast F.M., Kok F.J., et al. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005, 14:2943-2951.
24. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat Res 2001, 482:21-26.
25. Khan A.J., Choudhuri G., Husain Q., Parmar D. Polymorphism in glutathione-S-transferases: a risk factor in alcoholic liver cirrhosis. Drug Alcohol Depend 2009, 101:183-190.
26. Kordi-Tamandani D.M., Moazeni-Roodi A.K., Rigi-Ladiz M.A., Hashemi M., Birjandian E., Torkamanzehi A. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. Arch Oral Biol 2010, 55:809-814.
27. Sedlackova L., Nguyen T.T., Zlacka D., Sosna A., Hromadnikova I. Cell surface and relative mRNA expression of heat shock protein 70 in human synovial cells. Autoimmunity 2009, 42:17-24.
28. Struben V.M., Hespenheide E.E., Caldwell S.H. Non alcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000, 108:9-13.
29. Willner I.R., Waters B., Patil S.R., Reuben A., Morelli J., Riely C.A. Ninety patients with non alcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001, 96:2957-2961.
30. Caldwell S.H., Harris D.M., Patrie J.T., Hespenheide E.E. Is NASH underdiagnosed among African Americans?. Am J Gastroenterol 2002, 97:1496-1500.
31. Bromberger J.T., Harlow S., Avis N., Kravitz H.M., Cordal A. Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: the Study of Women's Health Across the Nation (SWAN). Am J Public Health 2004, 94:1378-1385.
32. Voso M.T., D'Alo F., Putzulu R., Mele L., Scardocci A., Chiusolo P., et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002, 100:2703-2707.
33. Bastian P.J., Nakayama M., De Marzo A.M., Nelson W.G. GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer. Urologe A 2004, 43:573-579.
34. Kim J., Lee H.S., Bae S.I., Lee Y.M., Kim W.H. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas. Anticancer Res 2005, 25:4013-4019.
35. Ronneberg J.A., Tost J., Solvang H.K., Alnaes G.I.G., Johansen F.E., Brendeford E.M., et al. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Cancer Res 2008, 68:5562-5571.
36. Wang J., Qin Y., Li B., Sun Z., Yang B. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem 2006, 39:344-348.
37. Rossini A., Rapozo D.C., Amorim L.M., Macedo J.M., Medina R., Neto J.F., et al. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 2002, 1:233-240.
38. Raimondi S., Paracchini V., Autrup H., Barros-Dios J.M., Benhamou S., Boffetta P., et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006, 164:1027-1042.
39. Garcia-Closas M., Kelsey K.T., Hankinson S.E., Spiegelman D., Springer K., Willett W.C., et al. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 1999, 91:1960-1964.
40. Kim W.J., Kim H., Kim C.H., Lee M.S., Oh B.R., Lee H.M., et al. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002, 60:913-918.
41. Garte S., Taioli E., Popov T., Kalina I., Sram R., Farmer P. Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans. Int J Cancer 2007, 120:2499-2503.